Based on the positive role of LSD1 downregulation on the anti-tumor activity of anti-CD19 CAR-T cells, we investigated the putative target genes regulated by LSD1 in LSD1-expressing anti-CD19 CAR-T cells by RNA-seq. This evidence concerns the gene KDM1A and neoplasm.